There was a high WBC in 2 of 3 cases.
Prognosis
Survival was 7 mths+, 42 mths+, and 87 mths+.
Genetics

Note
In the 3 cases reported by Akasaka et al (2007) , a CEBPB / IGH involvement was uncovered. (19q13) , all four equally implicated in leukemias, and DDIT3/CHOP/CEBP zeta (12q13), so far known to be involved in solid tumours (liposarcoma). These transcription factors play a key role in cellular differentiation, in particular in the control of myeloid differentiation. CEBPB is composed of a N-term transactivation domain, a negative regulatory domain, a DNA-binding basic motif, and a leucine-zipper domain in C-term. Different isoforms (LAP: liver activating protein, and LIP: liver inhibitory protein). CEBPB suppresses cell proliferation through repression of E2F target genes; on the other hand, CEBPB may promote tumorization of epithelial cells (Ramji et al., 2002; Nerlov et al., 2007) .
Genes involved and proteins
CEBPB
